In order to implement the Opinions of the General Office of the State Council on Reforming and Perfecting the Policy on the Supply and Use of Generic Drugs and the Notice on the Key Tasks for Deepening the Reform of the Medical and Health System in the Second Half of 2020 on the Deployment and Requirements for the Development of a Directory to Encourage Imitation Drugs, the National Health and Health Commission, in cooperation with the Ministry of Science and Technology, the Ministry of Industry and Information Technology, the Medical Insurance Bureau, the Intellectual Property Office, the Drug Administration and other departments, organized experts to select and demonstrate the selection and demonstration of medicines that are about to expire in 2021-2022.
is now made public for a period of 5 working days.
if you have any objections, you can give feedback to the Drug Division of the National Health And Health Commission through the following contact information.
: 010-68792519 Fax: 010-68792819 E-mail: firstname.lastname@example.org Feedback deadline is January 7, 2021.
: List of recommendations for the second batch of recommendations to encourage generic medicines National Health And Human Services Commission, 30 December 2020